Medicover

Medicover AB (publ) (“Medicover”) publishes the nomination committee’s composition for the annual general meeting (“AGM”) in 2025.

The nomination committee, which is appointed in accordance with the principles adopted by the annual general meeting on 26 April 2024, consists of:

• Fredrik Stenmo, representing Celox Holding AB and the Christina af Jochnick family’s total shareholding
• Hans Ramel, NG Invest Beta AB
• Jannis Kitsakis, Fjärde AP-Fonden
• Sophie Larsén, AMF och AMF Fonder

The Board of Medicover AB (publ)

For more information, please visit: medicover.com

Shareholders who wish to submit proposals to the nomination committee for the AGM to be held on 29 April 2025 can do so by e-mail to nominationcommittee@medicover.com or:

Medicover AB

Attn: Nomination Committee/General Legal Counsel

Box 5283, 102 46 Stockholm, Sweden

Proposals should be submitted to the nomination committee no later than 11 March 2025.

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations

+46 703 033 272
hanna.bjellquist@medicover.com

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2023, Medicover had revenue of €1,746 million and more than 45,000 employees. For more information, go to www.medicover.com